Log In
Print this Print this

Intelence, etravirine (TMC125)

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionNon-nucleoside reverse transcriptase inhibitor (NNRTI)
Molecular Target HIV reverse transcriptase
Mechanism of ActionNon-nucleoside reverse transcriptase inhibitor (NNRTI)
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection; Treat HIV infection/AIDS; Treat treatment-experienced HIV-1 infected adult patients
Regulatory Designation U.S. - Accelerated Approval (Treat HIV infection)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today